Akarsu, MesutÖnem, SonerTuran, İlkerAdalı, GupseAkdoğan, MeralAkyıldız, MuratAladağ, MuratBalaban, YaseminDanış, NilayDayangaç, MuratGençdal, GencoGökcan, HaleSertesen, ElifGürakar, MerveHarputluoğlu, MuratKabaçam, GökhanKarademir, SedatKıyıcı, Muratİdilman, RamazanKarasu, Zeki2021-10-212021-10-212021Akarsu, M., Önem, S., Turan, İ., Adalı, G., Akdoğan, M., Akyıldız, M. ... Karasu, Z. (2021). Recommendations for hepatitis B immunoglobulin and antiviral prophylaxis against hepatitis B recurrence after liver transplantation. Turkish Journal of Gastroenterology, 32(9), 712-719. https://dx.doi.org/10.5152/tjg.2021.216082148-5607https://dx.doi.org/10.5152/tjg.2021.21608https://hdl.handle.net/20.500.12511/8492The combination of hepatitis B immunoglobulin and potent nucleos(t)ide analogs after liver transplantation is considered as the standard of care for prophylaxis against hepatitis B virus recurrence. However, the recommended doses, route of administration, and duration of HBIG administration remain unclear. Moreover, hepatitis B immunoglobulin-free prophylaxis with potent nucleos(t)ide analogs has shown promising disease outcomes in preventing hepatitis B virus recurrence. The current recommendations, produced by the Turkish Association for the Study of the Liver, Acute Liver Failure and Liver Transplantation Special Interest Group, suggest a reduced need for hepatitis B immunoglobulin administration with effective long-term suppression of hepatitis B virus replication using potent nucleos(t)ide analogs after liver transplantation.eninfo:eu-repo/semantics/embargoedAccessHepatitis BLiver TransplantationRecurrenceReview Article32971271910.5152/tjg.2021.21608Q4512595Q3